From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Viva-Webinar

More Like This

PR Newswire associated0

Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery

PR Newswire associated0

Fifteen Years Alongside Europe's Drug Discovery Teams: Viva Biotech Strengthens Continuity from Discovery to Development and Manufacturing

PR Newswire associated0

Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities

PR Newswire associated0

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech's Discovery Insights

PR Newswire associated0

Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA

PR Newswire associated0

Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery, Upcoming Webinar Hosted by HitGen and Xtalks

PR Newswire associated0

Advancing DEL Technology for the Research Lab: HitGen Introduces OpenDEL™ 5.0